Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons

Journal of the American Geriatrics Society

Volumn 63, Issue 2, 2015, Pages 251-257

  Marcus, Brian S ^a   McAvay, Gail ^a   Gill, Thomas M ^a   Vaz Fragoso, Carlos A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

respiratory impairment; respiratory symptoms; spirometry; Z scores

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC BRONCHITIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSPNEA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREDICTIVE VALUE; RESPIRATORY TRACT DISEASE; SPIROMETRY; WHEEZING; AGE; BRONCHITIS, CHRONIC; COMPLICATION; FEMALE; MALE; NUTRITION; PREVALENCE; RESPIRATORY SOUNDS; VERY ELDERLY; VITAL CAPACITY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; BRONCHITIS, CHRONIC; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RESPIRATORY SOUNDS; SPIROMETRY; VITAL CAPACITY;

EID: 84923218401     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13242     Document Type: Article

References (38)

1. Kroenke K, Arrington ME, Mangelsdorff AD,. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150: 1685-1689.
2. American Thoracic Society Statement. Update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
3. Gardener EA, Huppert FA, Guralnik JM, et al. Middle-aged and mobility-limited: Prevalence of disability and symptom attributions in a national survey. J Gen Intern Med 2006; 21: 1091-1096.
4. Eriksson H, Svärdsudd K, Larsson B, et al. Dyspnoea in a cross-sectional and a longitudinal study of middle-aged men: The Study of Men Born in 1913 and 1923. Eur Heart J 1987; 8: 1015-1023.
5. Huijnen B, van der Horst F, van Amelsvoort L, et al. Dyspnea in elderly family practice patients. Occurrence, severity, quality of life and mortality over an 8-year period. Fam Pract 2006; 23: 34-39.
6. Abidov A, Rozanski A, Hachamovitch R, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 2005; 353: 1889-1898.
7. Enright P, Kronmal RA, Higgins MW, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994; 106: 827-834.
8. Ball P,. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108: 43S-52S.
9. Raherison C, Girodet P-O,. Epidemiology of COPD. Eur Respir Rev 2009; 18: 213-221.
10. Montes de Oca M, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: The PLATINO Study. Eur Respir J 2012; 40: 28-36.
11. Arif AA, Delclos GL, Lee ES, et al. Prevalence and risk factors of asthma and wheezing among US adults: An analysis of the NHANES III data. Eur Respir J 2003; 21: 827-833.
12. Bodner C, Ross S, Douglas G, et al. The prevalence of adult onset wheeze: Longitudinal study. BMJ 1997; 314: 792-793.
13. Vaz Fragoso CA, Gill T,. Respiratory impairment and the aging lung: A novel paradigm for assessing pulmonary function. J Gerontol A Biol Sci Med Sci 2012; 67A: 264-275.
14. Vestbo J, Hurd SS, Agusti AG, et al. GOLD executive summary. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 347-365.
15. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824.
16. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
17. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008; 177: 253-260.
18. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: The Global Lung Function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
19. Glady CA, Aaron SD, Lunau M, et al. Spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 2003; 123: 1939-1946.
20. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897-906.
21. Miller MR, Pincock AC,. Predicted values: How should we use them? Thorax 1988; 43: 265-267.
22. Fried TR, Vaz Fragoso CA, Rabow MW,. Caring for the older person with chronic obstructive pulmonary disease. JAMA 2012; 308: 1254-1263.
23. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005; 294: 716-724.
24. Vaz Fragoso CA, Gill TM, McAvay G, et al. Respiratory impairment in older persons: When less means more. Am J Med 2013; 126: 49-57.
25. Vaz Fragoso CA, Concato J, McAvay G, et al. Respiratory impairment and COPD hospitalization: A competing risk analysis. Eur Respir J 2012; 40: 37-44.
26. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
27. U.S. Department of Health and Human Services. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-94, NHANES III Laboratory Data File (CD-ROM), Public Use Data File Documentation Number 76200. Hyattsville, MD: Centers for Disease Control and Prevention, 1996.
28. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
29. Becklake M, Crapo RO, Buist S, et al. on behalf of the American Thoracic Society. Lung function testing: Selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
30. Vaz Fragoso CA, McAvay G, Gill TM, et al. Ethnic differences in respiratory impairment. Thorax 2014; 69: 55-62.
31. Gonzalez AB, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-2219.
32. Salome CM, King GG, Berend N,. Physiology of obesity and effects on lung function. J Appl Physiol 2010; 108: 206-211.
33. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61: 938-943.
34. Faner R, Tal-Singer R, Riley JH, et al. Lessons from ECLIPSE: A review of COPD biomarkers. Thorax 2014; 69: 666-672.
35. Feinstein AR,. The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. J Clin Epidemiol 1990; 43: 109-113.
36. American Thoracic Society/American College of Chest Physicians. (ATS/ACCP). Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277.
37. Schoenborn CA, Adams PF,. Health Behaviors of Adults: United States, 2005-2007. Data from the National Health Interview Survey (DHHS Publication No. (PHS) 2010-1573), Hyattsville, MD: U.S. Department of Health and Human Services, 2010.
38. Connolly MJ, Crowley JJ, Charan NB, et al. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax 1992; 47: 410-413.